Halbert Hargrove Global Advisors
GSK icon

Halbert Hargrove Global Advisors’s GSK GSK Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-46
Closed -$2.42K – 507
2026
Q2 		$2.42K Buy
+46
New +$2.43K ﹤0.01% 374
2025
Q4 		– Sell
-720
Closed -$31.1K – 530
2025
Q3 		$31.1K Buy
+720
New +$28.1K ﹤0.01% 212
2025
Q2 		– Sell
-13
Closed -$506 – 452
2025
Q1 		$506 Buy
+13
New +$476 ﹤0.01% 500

Other funds holding GSK

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Keystone Financial Planning
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
Bell Bank
Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Halbert Hargrove Global Advisors's GSK Position: Q3 2026 in Review

Halbert Hargrove Global Advisors sold out of GSK (GSK) in Q3 2026, closing a stake of 46 shares — an estimated $2.42K sold.

Halbert Hargrove Global Advisors first reported a position in GSK in Q1 2025 and held it in 3 quarters. The position peaked at $31.1K in Q3 2025. 266 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Halbert Hargrove Global Advisors reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 46 GSK shares in Q3 2026, an estimated $2.42K.
  • Halbert Hargrove Global Advisors first reported a position in GSK in Q1 2025 and held it in 3 quarters.
  • Halbert Hargrove Global Advisors's GSK position peaked at $31.1K in Q3 2025.
  • 266 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.